ÂÜÀòÂÒÂ×

The Business Development and Strategy team at Asklepios BioPharmaceutical focuses on identifying new market opportunities, forming strategic partnerships, and driving the commercialization of AAV gene therapies. They collaborate closely with clinical and operational teams to align business objectives with the company’s innovative pipeline, ensuring the successful delivery of therapies for genetic disorders.